ClinicalTrials.gg
Drug

Edotreotide yttrium y-90 clinical trials

Also written 90Y-DOTATOC.

studies test it
5
open now
0
in phase 3
0
first study started
2008

How each study uses edotreotide yttrium y-90 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Other names

90Y-DOTATOC
2

Studies by the year they started

5 studies that test it; most in 2017 (2)

Studies that test edotreotide yttrium y-90, by start year
YearStudies
20081
20161
20172
20181

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 2
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 1 · Other 4

David Bushnell (1) · Thomas Hope (1) · Sandeep Laroia (1) · Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (1) · Molecular Insight Pharmaceuticals, Inc. (1)

Often tested with

Tested in the same studies.

3-Iodobenzylguanidine (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses edotreotide yttrium y-90 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 5

Codes

What other systems call edotreotide yttrium y-90 · ClinicalTrials.gg INT004742

  • UNII (FDA) ABF7OG3FA3EDOTREOTIDE YTTRIUM Y-90Confirmed FDA, NLM, Wikidata
  • Wikidata Q27273846edotreotide yttrium y-90Confirmed FDA, NLM, Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.